Exosomes in Cancer: The Biology, Function, Diagnosis, and Therapy.
- 1Departments of Neurosurgery National Clinical Research Center for Geriatric Disorders (Xiangya Hospital) Central South University Changsha China.
- 2Department of Neurosurgery The Second Affiliated Hospital of Nanchang University Nanchang China.
- 3Departments of Neurosurgery National Regional Center for Neurological Diseases Xiangya Hospital Central South University Jiangxi China.
Abstract
Exosomes are central mediators of intercellular communication in the tumor microenvironment, transferring proteins, lipids, metabolites, and nucleic acids that regulate cancer progression. Recent advances in multi-omics and extracellular vesicle profiling have revealed substantial molecular and functional heterogeneity, extending beyond classical membrane-bound exosomes to nonmembranous extracellular nanoparticles such as exomeres and supermeres. Here, we provide a pan-cancer synthesis of exosome biology, integrating mechanisms of biogenesis, cargo sorting, and secretion with emerging concepts of extracellular nanoparticle diversity. We examine how tumor-derived exosomes remodel local and distant microenvironments by promoting angiogenesis, metabolic reprogramming, immune suppression, premetastatic niche formation, and cancer-associated cachexia. We also discuss the relative contributions of active organotropic targeting and passive spatiotemporal accumulation to metastatic dissemination, together with tissue-specific mechanisms governing endothelial barrier crossing, myeloid-cell reprogramming, and intercellular network integration. Clinically, we evaluate exosome-based liquid biopsy, molecular subtyping, engineered delivery systems, and strategies that inhibit endogenous vesicle production or circulation. Finally, we outline key translational challenges, including single-vesicle heterogeneity, limited intravital tracking, and the absence of standardized cGMP manufacturing and analytical frameworks across diverse tumor types and clinically relevant biological contexts worldwide. This review defines a roadmap for exosome-guided precision oncology.
Related
- Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy.
- CAR-NK cell-derived exosomes in cancer therapy: bridging cellular immunotherapy and nanomedicine
- Stem cell-derived exosomes in the therapy of renal diseases: a comprehensive review.
- Engineered Natural Membrane Vesicle Exosomes as a Torin2 Delivery Platform for Targeted Therapy of Anaplastic Thyroid Carcinoma.
- Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk Stratification
BibTeX
@article{wu2026exosomes,
title = {{Exosomes in Cancer: The Biology, Function, Diagnosis, and Therapy.}},
author = {Jun Wu and Lei Wu and Kang Yang and Kang Xie and Tao Lu and Tiangxiang Huang and Dengfeng Wan and Tao Song and Longbo Zhang},
journal = {MedComm},
year = {2026},
month = oct,
doi = {10.1002/mco2.71074},
url = {https://europepmc.org/article/MED/42910351},
note = {CC BY},
}
RIS
TY - JOUR
TI - Exosomes in Cancer: The Biology, Function, Diagnosis, and Therapy.
AU - Jun Wu
AU - Lei Wu
AU - Kang Yang
AU - Kang Xie
AU - Tao Lu
AU - Tiangxiang Huang
AU - Dengfeng Wan
AU - Tao Song
AU - Longbo Zhang
PY - 2026
DA - 2026/10/21
JO - MedComm
DO - 10.1002/mco2.71074
UR - https://europepmc.org/article/MED/42910351
AB - Exosomes are central mediators of intercellular communication in the tumor microenvironment, transferring proteins, lipids, metabolites, and nucleic acids that regulate cancer progression. Recent advances in multi-omics and extracellular vesicle profiling have revealed substantial molecular and functional heterogeneity, extending beyond classical membrane-bound exosomes to nonmembranous extracellular nanoparticles such as exomeres and supermeres. Here, we provide a pan-cancer synthesis of exosome biology, integrating mechanisms of biogenesis, cargo sorting, and secretion with emerging concepts of extracellular nanoparticle diversity. We examine how tumor-derived exosomes remodel local and distant microenvironments by promoting angiogenesis, metabolic reprogramming, immune suppression, premetastatic niche formation, and cancer-associated cachexia. We also discuss the relative contributions of active organotropic targeting and passive spatiotemporal accumulation to metastatic dissemination, together with tissue-specific mechanisms governing endothelial barrier crossing, myeloid-cell reprogramming, and intercellular network integration. Clinically, we evaluate exosome-based liquid biopsy, molecular subtyping, engineered delivery systems, and strategies that inhibit endogenous vesicle production or circulation. Finally, we outline key translational challenges, including single-vesicle heterogeneity, limited intravital tracking, and the absence of standardized cGMP manufacturing and analytical frameworks across diverse tumor types and clinically relevant biological contexts worldwide. This review defines a roadmap for exosome-guided precision oncology.
SN - 2688-2663
ER -